サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414454

高眼圧症治療の世界市場レポート 2024年

Ocular Hypertension Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
高眼圧症治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

高眼圧症治療の市場規模は近年着実に成長しています。2023年の51億4,000万米ドルから2024年には53億4,000万米ドルへとCAGR3.7％で拡大します。歴史的な期間中に観察された拡大は、高齢化人口の増加、緑内障の発生の高まり、診断技術の進歩、スクリーニングへの認識とアクセスの向上、ライフスタイルのシフト、都市化の進行傾向などのいくつかの要因に起因しています。

緑内障の有病率の高まりは、高眼圧症治療市場の拡大を牽引すると予想されます。緑内障は、視神経を損傷することで視力障害や失明につながる可能性のある慢性的な目の病気であり、高眼圧症と直接的な関連があり、永続的な視力障害を引き起こす目の疾患群の一因となっています。2022年10月にBrightFocus Foundation Highlightsが発表した予測では、世界全体で8,000万人が緑内障に罹患しており、2040年には1億1,100万人以上に急増すると予測されています。この緑内障患者数の増加が高眼圧症治療市場の成長を裏付けています。

2023年の高眼圧症治療市場で最大の地域は北米です。高眼圧症治療市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の高眼圧症治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 眼内高血圧
  • 緑内障
  • 世界の高眼圧症治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の高眼圧症治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他
  • 世界の高眼圧症治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の高眼圧症治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の高眼圧症治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 高眼圧症治療市場の競合情勢
  • 高眼圧症治療市場の企業プロファイル
    • Angelini SpA
    • Laboratorios Sophia
    • Neurim Pharmaceuticals Ltd.
    • Nicox SA
    • Novartis AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11964

“Ocular Hypertension Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular hypertension treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular hypertension treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The ocular hypertension treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Intraocular Hypertension; Glaucoma
  • 2) By Route of Administration: Oral; Parenteral; Other Routes
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel
  • 4) By End-Users: Hospitals; Specialty Clinics; Others End-Users
  • Companies Mentioned: Angelini SpA; Laboratorios Sophia; Neurim Pharmaceuticals Ltd.; Nicox SA; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Ocular hypertension treatment encompasses strategies aimed at managing and lowering elevated intraocular pressure (IOP) in individuals diagnosed with this condition. This treatment is crucial for safeguarding the optic nerve, preserving visual function, and maintaining overall ocular health.

The primary categories of ocular hypertension treatment involve addressing intraocular pressure and managing glaucoma. Intraocular hypertension specifically denotes heightened pressure within the eye, particularly in the fluid-filled anterior chamber. These treatments are delivered through oral, parenteral, and various other administration routes, distributed across hospital pharmacies, retail outlets, online platforms, and similar channels. The key end-users of ocular hypertension treatment include hospitals, specialized clinics, and related establishments.

The ocular hypertension treatment market research report is one of a series of new reports from The Business Research Company that provides ocular hypertension treatment market statistics, including the ocular hypertension treatment industry's global market size, regional shares, competitors with an ocular hypertension treatment market share, detailed ocular hypertension treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the ocular hypertension treatment industry. This ocular hypertension treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ocular hypertension treatment market size has grown steadily in recent years. It will grow from $5.14 billion in 2023 to $5.34 billion in 2024 at a compound annual growth rate (CAGR) of 3.7%. The expansion observed during the historical period can be credited to several factors such as a rise in the aging population, heightened occurrence of glaucoma, advancements in diagnostic technologies, increased awareness and accessibility to screenings, lifestyle shifts, and the ongoing trend of urbanization.

The ocular hypertension treatment market size is expected to see steady growth in the next few years. It will grow to $6.1 billion in 2028 at a compound annual growth rate (CAGR) of 3.4%. The anticipated growth in the forecasted period is expected to stem from the upward trajectory of global healthcare spending, continuous advancements in treatment methodologies, a heightened focus on personalized medicine, the integration and widespread adoption of telehealth services, and the increasing population of older adults. Notable trends projected in the forecast period encompass patient-centric approaches, the influence of regulatory landscapes, global market expansion, technological enhancements in monitoring devices, and the integration of artificial intelligence (AI).

The escalating prevalence of glaucoma is anticipated to drive the expansion of the ocular hypertension treatment market. Glaucoma, a chronic eye ailment leading to potential vision impairment and blindness by damaging the optic nerve, has a direct link to ocular hypertension, contributing to a cluster of eye conditions causing lasting visual impairment. Projections from the BrightFocus Foundation Highlights in October 2022 indicated that globally, 80 million individuals were affected by glaucoma, with estimates predicting a surge to over 111 million by 2040. This projected rise in glaucoma instances substantiates the growth of the ocular hypertension treatment market.

The growth of the aging demographic is poised to fuel advancements in the ocular hypertension treatment market. As populations age due to declining birth rates and extended life expectancy, ocular hypertension becomes more prevalent. Heightened intraocular pressure risk elevates with age, underscoring the significance of regular eye screenings for early detection and management. Forecasts from the ARC Centre of Excellence in Population Ageing Research suggest Australia's 65-and-above population could grow to 6.66 million by 2041 from an estimated 4.31 million in 2021, marking a 54% increase. This demographic shift substantiates the expansion of the ocular hypertension treatment market.

Innovation stands as a prominent trend propelling the ocular hypertension treatment market. Companies within this sector are actively embracing novel technologies to fortify their market standing. For instance, in April 2022, Sandoz, a Switzerland-based generics and biosimilars manufacturer, introduced the Brimonidine tartrate/timolol maleate ophthalmic solution. This eye drop combination, available in generic forms of 0.2% or 0.5%, effectively reduces eye pressure in individuals with ocular hypertension. Fixed medication combinations offer patients simplicity, improved compliance, reduced exposure to preservatives, and potential cost savings.

Notable players in the ocular hypertension treatment market are forging strategic partnerships and collaborations to fortify their market presence. These alliances, formed to achieve specific business objectives, are gaining prominence. For instance, in July 2022, AbbVie Inc., a US-based pharmaceutical firm, announced a strategic collaboration with iSTAR Medical SA, a Belgian clinical-stage medical technology company, to advance and commercialize the MINIject device. This minimally invasive glaucoma surgical (MIGS) device, designed to reduce intraocular pressure in primary open-angle glaucoma patients, expands AbbVie's eye care portfolio. The collaboration aims to expedite the development and market availability of the MINIject device, offering a novel treatment avenue for glaucoma patients.

In November 2022, Alcon, a pharmaceutical and medical device company headquartered in the US, completed the acquisition of Aerie Pharmaceuticals Inc., a clinical-stage pharmaceutical firm based in the US, for an undisclosed amount. This strategic acquisition significantly enhances Alcon's portfolio of commercial offerings and bolsters its developmental pipeline within the ocular hypertension treatment market.

Major companies operating in the ocular hypertension treatment market report are Angelini SpA, Laboratorios Sophia, Neurim Pharmaceuticals Ltd., Nicox SA, Novartis AG, AbbVie Inc., Alcon, Ocular Therapeutix Inc., Sylentis S.A, Taejoon Pharma Co. Ltd., Bausch Health Companies Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Laboratorios Salvat SA, Shionogi & Co. Ltd., Otsuka Holdings Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Eisai Co. Ltd., Daiichi Sankyo Company Limited, Celgene Corporation, Boehringer Ingelheim International GmbH, Eurofins Discover X Corporation, Novus Biologicals LLC, SK Bioscience Co., Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited

North America was the largest region in the ocular hypertension treatment market in 2023. The regions covered in the ocular hypertension treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ocular hypertension treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ocular hypertension treatment market includes revenues earned by entities by providing carbonic anhydrase inhibitors, prostaglandins, and beta-blockers that are used to treat ocular hypertension. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Ocular Hypertension Treatment Market Characteristics

3. Ocular Hypertension Treatment Market Trends And Strategies

4. Ocular Hypertension Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Ocular Hypertension Treatment Market Size and Growth

  • 5.1. Global Ocular Hypertension Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ocular Hypertension Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ocular Hypertension Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ocular Hypertension Treatment Market Segmentation

  • 6.1. Global Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intraocular Hypertension
  • Glaucoma
  • 6.2. Global Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes
  • 6.3. Global Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Other Distribution Channel
  • 6.4. Global Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Others End-Users

7. Ocular Hypertension Treatment Market Regional And Country Analysis

  • 7.1. Global Ocular Hypertension Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ocular Hypertension Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ocular Hypertension Treatment Market

  • 8.1. Asia-Pacific Ocular Hypertension Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ocular Hypertension Treatment Market

  • 9.1. China Ocular Hypertension Treatment Market Overview
  • 9.2. China Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ocular Hypertension Treatment Market

  • 10.1. India Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ocular Hypertension Treatment Market

  • 11.1. Japan Ocular Hypertension Treatment Market Overview
  • 11.2. Japan Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ocular Hypertension Treatment Market

  • 12.1. Australia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ocular Hypertension Treatment Market

  • 13.1. Indonesia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ocular Hypertension Treatment Market

  • 14.1. South Korea Ocular Hypertension Treatment Market Overview
  • 14.2. South Korea Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ocular Hypertension Treatment Market

  • 15.1. Western Europe Ocular Hypertension Treatment Market Overview
  • 15.2. Western Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ocular Hypertension Treatment Market

  • 16.1. UK Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ocular Hypertension Treatment Market

  • 17.1. Germany Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ocular Hypertension Treatment Market

  • 18.1. France Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ocular Hypertension Treatment Market

  • 19.1. Italy Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ocular Hypertension Treatment Market

  • 20.1. Spain Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ocular Hypertension Treatment Market

  • 21.1. Eastern Europe Ocular Hypertension Treatment Market Overview
  • 21.2. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ocular Hypertension Treatment Market

  • 22.1. Russia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ocular Hypertension Treatment Market

  • 23.1. North America Ocular Hypertension Treatment Market Overview
  • 23.2. North America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ocular Hypertension Treatment Market

  • 24.1. USA Ocular Hypertension Treatment Market Overview
  • 24.2. USA Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ocular Hypertension Treatment Market

  • 25.1. Canada Ocular Hypertension Treatment Market Overview
  • 25.2. Canada Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ocular Hypertension Treatment Market

  • 26.1. South America Ocular Hypertension Treatment Market Overview
  • 26.2. South America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ocular Hypertension Treatment Market

  • 27.1. Brazil Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ocular Hypertension Treatment Market

  • 28.1. Middle East Ocular Hypertension Treatment Market Overview
  • 28.2. Middle East Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ocular Hypertension Treatment Market

  • 29.1. Africa Ocular Hypertension Treatment Market Overview
  • 29.2. Africa Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ocular Hypertension Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Ocular Hypertension Treatment Market Competitive Landscape
  • 30.2. Ocular Hypertension Treatment Market Company Profiles
    • 30.2.1. Angelini SpA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Laboratorios Sophia
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Neurim Pharmaceuticals Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Nicox SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Ocular Hypertension Treatment Market Competitive Benchmarking

32. Global Ocular Hypertension Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Ocular Hypertension Treatment Market

34. Ocular Hypertension Treatment Market Future Outlook and Potential Analysis

  • 34.1 Ocular Hypertension Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Ocular Hypertension Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Ocular Hypertension Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer